168 related articles for article (PubMed ID: 36878561)
1. Update in the molecular classification of endometrial carcinoma.
Léon-Castillo A
Int J Gynecol Cancer; 2023 Mar; 33(3):333-342. PubMed ID: 36878561
[TBL] [Abstract][Full Text] [Related]
2. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
3. Identification of
Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
[TBL] [Abstract][Full Text] [Related]
5. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.
Talhouk A; Hoang LN; McConechy MK; Nakonechny Q; Leo J; Cheng A; Leung S; Yang W; Lum A; Köbel M; Lee CH; Soslow RA; Huntsman DG; Gilks CB; McAlpine JN
Gynecol Oncol; 2016 Oct; 143(1):46-53. PubMed ID: 27421752
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights into the classification of high-grade endometrial carcinoma.
Hussein YR; Soslow RA
Pathology; 2018 Feb; 50(2):151-161. PubMed ID: 29246451
[TBL] [Abstract][Full Text] [Related]
7. High-grade endometrial carcinomas: Morphologic spectrum and molecular classification.
Zhang C; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):176-186. PubMed ID: 34852949
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Rau TT; Bettschen E; Büchi C; Christe L; Rohner A; Müller MD; Carlson JW; Imboden S; Zlobec I
Mod Pathol; 2021 Jan; 34(1):222-232. PubMed ID: 32728223
[TBL] [Abstract][Full Text] [Related]
9. A potpourri of pathogenetic pathways in endometrial carcinoma with a focus on Lynch Syndrome.
Wadee R; Grayson W
Ann Diagn Pathol; 2019 Apr; 39():92-104. PubMed ID: 30798077
[TBL] [Abstract][Full Text] [Related]
10. A clinically applicable molecular-based classification for endometrial cancers.
Talhouk A; McConechy MK; Leung S; Li-Chang HH; Kwon JS; Melnyk N; Yang W; Senz J; Boyd N; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Br J Cancer; 2015 Jul; 113(2):299-310. PubMed ID: 26172027
[TBL] [Abstract][Full Text] [Related]
11. Endometrial Cancer: Transitioning from Histology to Genomics.
Mitric C; Bernardini MQ
Curr Oncol; 2022 Jan; 29(2):741-757. PubMed ID: 35200562
[TBL] [Abstract][Full Text] [Related]
12. Endometrial Cancer: An Update on Prognostic Pathologic Features and Clinically Relevant Biomarkers.
Li JJX; Ip PPC
Surg Pathol Clin; 2022 Jun; 15(2):277-299. PubMed ID: 35715162
[TBL] [Abstract][Full Text] [Related]
13. [Histological and molecular classification of endometrial carcinoma and therapeutical implications].
Genestie C; Leary A; Devouassoux M; Auguste A
Bull Cancer; 2017 Dec; 104(12):1001-1012. PubMed ID: 29031505
[TBL] [Abstract][Full Text] [Related]
14. Classification of endometrial carcinoma: more than two types.
Murali R; Soslow RA; Weigelt B
Lancet Oncol; 2014 Jun; 15(7):e268-78. PubMed ID: 24872110
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of molecular characteristics into endometrial cancer management.
Vermij L; Smit V; Nout R; Bosse T
Histopathology; 2020 Jan; 76(1):52-63. PubMed ID: 31846532
[TBL] [Abstract][Full Text] [Related]
16. The brave new world of endometrial cancer : Future implications for adjuvant treatment decisions.
Marnitz S; Waltar T; Köhler C; Mustea A; Schömig-Markiefka B
Strahlenther Onkol; 2020 Nov; 196(11):963-972. PubMed ID: 32430662
[TBL] [Abstract][Full Text] [Related]
17. Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
Nero C; Pasciuto T; Cappuccio S; Corrado G; Pelligra S; Zannoni GF; Santoro A; Piermattei A; Minucci A; Lorusso D; Fanfani F; Scambia G
Cancer; 2022 Aug; 128(15):2898-2907. PubMed ID: 35617463
[TBL] [Abstract][Full Text] [Related]
18. Use of mutation profiles to refine the classification of endometrial carcinomas.
McConechy MK; Ding J; Cheang MC; Wiegand K; Senz J; Tone A; Yang W; Prentice L; Tse K; Zeng T; McDonald H; Schmidt AP; Mutch DG; McAlpine JN; Hirst M; Shah SP; Lee CH; Goodfellow PJ; Gilks CB; Huntsman DG
J Pathol; 2012 Sep; 228(1):20-30. PubMed ID: 22653804
[TBL] [Abstract][Full Text] [Related]
19. Molecular Genetics of Endometrial Carcinoma.
Bell DW; Ellenson LH
Annu Rev Pathol; 2019 Jan; 14():339-367. PubMed ID: 30332563
[TBL] [Abstract][Full Text] [Related]
20. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
Wang M; Hui P
Arch Pathol Lab Med; 2021 Nov; 145(11):1367-1378. PubMed ID: 34673912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
